JPS6253923A - 活性型ビタミンｄ↓３類の軟カプセル剤 - Google Patents
活性型ビタミンｄ↓３類の軟カプセル剤Info
- Publication number
- JPS6253923A JPS6253923A JP19322185A JP19322185A JPS6253923A JP S6253923 A JPS6253923 A JP S6253923A JP 19322185 A JP19322185 A JP 19322185A JP 19322185 A JP19322185 A JP 19322185A JP S6253923 A JPS6253923 A JP S6253923A
- Authority
- JP
- Japan
- Prior art keywords
- soft capsule
- acid
- vitamin
- active vitamin
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 27
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract description 15
- 239000003795 chemical substances by application Substances 0.000 title abstract description 3
- 235000012730 carminic acid Nutrition 0.000 claims abstract description 17
- 239000003086 colorant Substances 0.000 claims abstract description 17
- 239000004106 carminic acid Substances 0.000 claims abstract description 15
- 229940114118 carminic acid Drugs 0.000 claims abstract description 15
- 239000000049 pigment Substances 0.000 claims abstract description 15
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 12
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims abstract description 9
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims abstract description 9
- 235000001046 cacaotero Nutrition 0.000 claims abstract description 9
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940117893 apigenin Drugs 0.000 claims abstract description 8
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000008714 apigenin Nutrition 0.000 claims abstract description 8
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 claims abstract description 4
- 241001071917 Lithospermum Species 0.000 claims abstract description 4
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 claims abstract description 4
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 claims abstract 4
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract description 14
- 235000005282 vitamin D3 Nutrition 0.000 abstract description 12
- 239000011647 vitamin D3 Substances 0.000 abstract description 12
- 229940021056 vitamin d3 Drugs 0.000 abstract description 12
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 abstract description 9
- 229960002535 alfacalcidol Drugs 0.000 abstract description 8
- RHAXKFFKGZJUOE-UHFFFAOYSA-N 7-acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid Chemical compound O=C1C2=CC(O)=C(C(O)=O)C(C(O)=O)=C2C(=O)C2=C1C(O)=C(CC)C(C(C)=O)=C2O RHAXKFFKGZJUOE-UHFFFAOYSA-N 0.000 abstract description 7
- 229930192967 Laccaic acid Natural products 0.000 abstract description 6
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 5
- 239000011612 calcitriol Substances 0.000 abstract description 4
- 235000020964 calcitriol Nutrition 0.000 abstract description 3
- 208000001132 Osteoporosis Diseases 0.000 abstract description 2
- 208000001647 Renal Insufficiency Diseases 0.000 abstract description 2
- 201000006370 kidney failure Diseases 0.000 abstract description 2
- 108010034984 D3 compound Proteins 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 4
- BJYLYJCXYAMOFT-RRXOBRNQSA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RRXOBRNQSA-N 0.000 description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000009470 Theobroma cacao Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000013736 caramel Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000219357 Cactaceae Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- -1 etc. Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- BWFQMABKLLTETH-YGQRWWDYSA-N (1S)-1,25-dihydroxy-24-oxocalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(=O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BWFQMABKLLTETH-YGQRWWDYSA-N 0.000 description 1
- SNOXQOOPUCMFPS-ZLNGONTQSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C SNOXQOOPUCMFPS-ZLNGONTQSA-N 0.000 description 1
- 239000004040 24-hydroxy-cholecalciferol Substances 0.000 description 1
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 description 1
- 239000004039 25-hydroxy-24-oxo-cholecalciferol Substances 0.000 description 1
- DDZHNKIBJQESJA-AHMPPUFCSA-N 25-hydroxy-24-oxocalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(=O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C DDZHNKIBJQESJA-AHMPPUFCSA-N 0.000 description 1
- 239000003872 25-hydroxy-cholecalciferol Substances 0.000 description 1
- DGQLVPJVXFOQEV-MPQDNOGBSA-N 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2r,4s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1OC(CO)C(O)[C@@H](O)C1O DGQLVPJVXFOQEV-MPQDNOGBSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000304867 Adromischus maculatus Species 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 235000021318 Calcifediol Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000000176 photostabilization Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19322185A JPS6253923A (ja) | 1985-09-03 | 1985-09-03 | 活性型ビタミンｄ↓３類の軟カプセル剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19322185A JPS6253923A (ja) | 1985-09-03 | 1985-09-03 | 活性型ビタミンｄ↓３類の軟カプセル剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6253923A true JPS6253923A (ja) | 1987-03-09 |
| JPH0327535B2 JPH0327535B2 (OSRAM) | 1991-04-16 |
Family
ID=16304327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19322185A Granted JPS6253923A (ja) | 1985-09-03 | 1985-09-03 | 活性型ビタミンｄ↓３類の軟カプセル剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6253923A (OSRAM) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04193825A (ja) * | 1990-11-26 | 1992-07-13 | Nippon Eranko Kk | 硬質ゼラチンカプセル |
| WO1999018953A1 (en) * | 1997-10-16 | 1999-04-22 | Children's Hospital Medical Center Of Northern California | Flavonoids for cystic fibrosis therapy |
| FR2814369A1 (fr) * | 2000-09-27 | 2002-03-29 | Spmd | Preparation medicamenteuse a base de vitamines d3 et son procede de fabrication |
| WO2005039541A1 (ja) * | 2003-10-24 | 2005-05-06 | Nisshin Pharma Inc. | コエンザイムｑ10含有カプセル剤 |
| JP2020183346A (ja) * | 2019-04-26 | 2020-11-12 | ロート製薬株式会社 | 経口組成物 |
-
1985
- 1985-09-03 JP JP19322185A patent/JPS6253923A/ja active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04193825A (ja) * | 1990-11-26 | 1992-07-13 | Nippon Eranko Kk | 硬質ゼラチンカプセル |
| WO1999018953A1 (en) * | 1997-10-16 | 1999-04-22 | Children's Hospital Medical Center Of Northern California | Flavonoids for cystic fibrosis therapy |
| FR2814369A1 (fr) * | 2000-09-27 | 2002-03-29 | Spmd | Preparation medicamenteuse a base de vitamines d3 et son procede de fabrication |
| WO2005039541A1 (ja) * | 2003-10-24 | 2005-05-06 | Nisshin Pharma Inc. | コエンザイムｑ10含有カプセル剤 |
| JP2020183346A (ja) * | 2019-04-26 | 2020-11-12 | ロート製薬株式会社 | 経口組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0327535B2 (OSRAM) | 1991-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2304432C2 (ru) | Средство снижения утомляемости | |
| KR100385600B1 (ko) | 중심 충전 당제 | |
| EP2424502B1 (en) | Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate | |
| ES2350822T3 (es) | Cápsulas blandas. | |
| US5073376A (en) | Preparations containing l-carnitine | |
| JP3527890B2 (ja) | フマル酸アルキル水素エステルからなる乾癬、乾癬性関節炎、神経皮膚炎および限局性回腸炎クローン病の治療剤 | |
| EP1575378A1 (de) | Pulverförmige phytosterol-formulierungen | |
| AU618154B2 (en) | Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same | |
| US6197813B1 (en) | Stable liquid mineral ascorbate compositions and methods of manufacture and use | |
| JP2003119127A (ja) | 安定な還元型補酵素ｑ製剤 | |
| CA2512988A1 (en) | Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same | |
| EA018580B1 (ru) | Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза | |
| KR20080028374A (ko) | 베타-알라닌의 지속형 방출을 위한 조성물 및 방법 | |
| IE902529A1 (en) | Antiseptic compositions containing¹hexahydro-5-pyrimidinamine compounds and an amphoteric¹surfactant and methods for preparing same | |
| WO2018064468A1 (en) | Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth | |
| KR19990076491A (ko) | 글리코실-엘-아스코르브산의 아실화 유도체 | |
| CN109640935A (zh) | 包含（e）-3-苯并[1,3]二氧杂环戊烯-5-基-n,n-二苯基-2-丙烯酰胺的混合物 | |
| JPS6253923A (ja) | 活性型ビタミンｄ↓３類の軟カプセル剤 | |
| JP2000095666A (ja) | リップクリーム | |
| JPH04288016A (ja) | 活性型ビタミンｄ３類軟カプセル剤の製造方法 | |
| SK121699A3 (en) | Stable solid preparation containing vitamin d3 and tricalcium phosphate | |
| US20100150894A1 (en) | Composition for prevention of cancer | |
| IE57070B1 (en) | Foodstuffs,including chewing gum with anti-caries activity,and processes for preparing them | |
| JPH0899872A (ja) | 異臭のない安定なカロチノイド製剤の製造法 | |
| EP1747778B1 (en) | Anti-fatigue composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |